# Editorial: Immunomodulatory strategies for managing viral infections: host immune responses and therapeutic targets

**Authors:** Pratibha Gaur, Ekta Khattar, Ramendra Pati Pandey

PMC · DOI: 10.3389/fcimb.2026.1795797 · Frontiers in Cellular and Infection Microbiology · 2026-02-12

## Full-text entities

- **Genes:** TRIM33 (tripartite motif containing 33) [NCBI Gene 51592] {aka DDH4, ECTO, PTC7, RFG7, TF1G, TIF1G}, RSAD2 (radical S-adenosyl methionine domain containing 2) [NCBI Gene 91543] {aka SAND, cig33, cig5, vig1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, IL6R (interleukin 6 receptor) [NCBI Gene 3570] {aka CD126, HIES5, IL-1Ra, IL-6R, IL-6R-1, IL-6RA}, TRIM24 (tripartite motif containing 24) [NCBI Gene 8805] {aka PTC6, RNF82, TF1A, TIF1, TIF1A, TIF1ALPHA}, TRIM28 (tripartite motif containing 28) [NCBI Gene 10155] {aka KAP1, PPP1R157, RNF96, TF1B, TIF1B, TIF1beta}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** infection (MESH:D007239), COVID-19 (MESH:D000086382), Viral infections (MESH:D014777), inflammatory (MESH:D007249)
- **Chemicals:** tocilizumab (MESH:C502936)
- **Species:** Homo sapiens (human, species) [taxon 9606], Influenza A virus (no rank) [taxon 11320], Roseomonas sp. P (species) [taxon 589294], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Human immunodeficiency virus 1 (no rank) [taxon 11676], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935676/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935676/full.md

---
Source: https://tomesphere.com/paper/PMC12935676